drug
as of 2026-07-01HTC-867
at a glance
small molecule
Pre-approval / investigational in the US
Developed by Wyeth is now a wholly owned subsidiary of Pfizer
2 trials in the graph
Synthesized from structured facts only — each point cited above.
Mechanism & identity
Modality
small molecule
Indications
Investigational (via trials)
Trials
2
Study Evaluating HTC-867 in Healthy Young and Elderly Subjects
NCT00827489Phase 1Terminated
Study Evaluating The Safety and Tolerability of HTC-867 in Healthy Japanese Subjects
NCT01268124Phase 1Completed
Facts & assertions
0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
developer
trial
indication